RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Chembio Diagnostics Stock

Chembio Diagnostics Equity 2024

Chembio Diagnostics Equity

17.8 M USD

Ticker

CEMI

ISIN

US1635722093

WKN

A1JY4D

In 2024, Chembio Diagnostics's equity was 17.8 M USD, a -48.06% increase from the 34.26 M USD equity in the previous year.

Chembio Diagnostics Aktienanalyse

What does Chembio Diagnostics do?

Chembio Diagnostics Inc is a biomedical company specializing in the development and commercialization of diagnostic test kits. The company was founded in 1985 and is headquartered in Medford, New York. Chembio Diagnostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Chembio Diagnostics's Equity

Chembio Diagnostics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Chembio Diagnostics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Chembio Diagnostics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Chembio Diagnostics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Chembio Diagnostics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Chembio Diagnostics stock

What is the equity of Chembio Diagnostics this year?

Chembio Diagnostics has equity of 17.8 M USD this year.

What was the equity of Chembio Diagnostics compared to the previous year?

The equity of Chembio Diagnostics has increased/decreased by -48.06% decreased compared to the previous year.

What impact does a high equity have on investors of Chembio Diagnostics?

A high equity is advantageous for investors of Chembio Diagnostics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Chembio Diagnostics?

A low equity can be a risk for investors of Chembio Diagnostics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Chembio Diagnostics affect the company?

An increase in equity of Chembio Diagnostics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Chembio Diagnostics affect the company?

A reduction in equity of Chembio Diagnostics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Chembio Diagnostics?

Some factors that can affect the equity of Chembio Diagnostics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Chembio Diagnostics so important for investors?

The equity of Chembio Diagnostics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Chembio Diagnostics take to change the equity?

To change equity, Chembio Diagnostics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Chembio Diagnostics pay?

Over the past 12 months, Chembio Diagnostics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Chembio Diagnostics is expected to pay a dividend of 0 USD.

What is the dividend yield of Chembio Diagnostics?

The current dividend yield of Chembio Diagnostics is .

When does Chembio Diagnostics pay dividends?

Chembio Diagnostics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Chembio Diagnostics?

Chembio Diagnostics paid dividends every year for the past 0 years.

What is the dividend of Chembio Diagnostics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Chembio Diagnostics located?

Chembio Diagnostics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Chembio Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chembio Diagnostics from 12/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/20/2024.

When did Chembio Diagnostics pay the last dividend?

The last dividend was paid out on 12/20/2024.

What was the dividend of Chembio Diagnostics in the year 2023?

In the year 2023, Chembio Diagnostics distributed 0 USD as dividends.

In which currency does Chembio Diagnostics pay out the dividend?

The dividends of Chembio Diagnostics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Chembio Diagnostics

Our stock analysis for Chembio Diagnostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chembio Diagnostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.